logo
15:57 May 29

Alivus Life Sciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1055.50
-14.80 (-1.38%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Alivus Life Sciences Ltd. Financials

Alivus Life Sciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1055.50
-14.80 (-1.38%)
15:57 May 29
Quality
image/svg+xml

64/100
High Financial Strength

Valuation
image/svg+xml

39/100
Mid Valuation

Technical

61/100
Technically Moderately Bullish

Strength

10

Weakness

5

Opportunity

1

Threats

0

16.94 %

ROE %

14.17 %

ROA %

45.99

EPS

271.49

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
2123.21 2161.22 2283.21 2386.88 2551.83
Operating Expenses +
1507.15 1518.93 1608.97 1704.3 1754.55
Raw Material
1001.56 1098.52 1058.58 1053.5 1063
Increase Decrease in Cost
41.32 -84.44 -56.57 27.35 3.56
Other Manufacturing Expense
2.66 2.48 3.17 2.43 0
Employee Cost
168.72 180.18 258.16 251.7 272.47
Miscellaneous Expenses
292.89 322.19 345.63 369.32 415.52
Operating Profit
616.06 642.29 674.24 682.58 797.28
Other Income
14.7 28.96 12.04 34.57 60.41
Depreciation
37.88 42.09 53.45 60.61 75.36
Interest
27.96 0.55 1.55 2.41 5.37
Profit before tax and exceptio..
564.92 628.61 631.29 654.13 776.97
Exceptional Items
0 0 0 0 -25.66
PBT
564.92 628.61 631.29 654.13 751.31
Provision for Taxation
146.2 161.65 160.4 168.5 186.83
Net Profit
418.72 466.96 470.89 485.63 564.48
NET Profit after MI
0 0 0 0 0
EPS
35.63 38.11 38.43 39.63 45.99
Operating Profit Margin (%)
29.02 29.72 29.53 28.6 31.24
Net Profit Margin (%)
19.72 21.61 20.62 20.35 22.12

Alivus Life Sciences Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: